{"abstract": "AbbVie will now pay Shire a $1.635 billion breakup fee \u2013 just weeks after the Treasury Department announced new rules taking aim at inversion deals.", "web_url": "https://dealbook.nytimes.com/2014/10/20/abbvie-and-shire-agree-to-terminate-their-deal/", "snippet": "AbbVie will now pay Shire a $1.635 billion breakup fee \u2013 just weeks after the Treasury Department announced new rules taking aim at inversion deals.", "lead_paragraph": "AbbVie\u2018s deal for Shire is officially off.", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-articleLarge.jpg", "height": 360, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 360}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-jumbo.jpg", "height": 614, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-superJumbo.jpg", "height": 1200, "width": 2000, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/10/16/business/dbpix-abbvie-tablets/dbpix-abbvie-tablets-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "After Tax Inversion Rules Change, AbbVie and Shire Agree to Terminate Their Deal", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Federal Taxes (US)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AbbVie Inc", "rank": 4, "major": "N"}, {"name": "organizations", "value": "ALLERGAN INC", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Shire PLC", "rank": 7, "major": "N"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": 8, "major": "N"}, {"name": "glocations", "value": "Great Britain", "rank": 9, "major": "N"}, {"name": "glocations", "value": "United States", "rank": 10, "major": "N"}], "pub_date": "2014-10-20T22:05:48+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By David Gelles", "person": [{"firstname": "David", "middlename": null, "lastname": "Gelles", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/65743165-5b7e-5c4b-aa6a-80844f54287a", "word_count": 579, "uri": "nyt://article/65743165-5b7e-5c4b-aa6a-80844f54287a"}